Evidence map›Paper›PMID 29143599›Full record

ArticleBMC genomics2017

Epistasis, physical capacity-related genes and exceptional longevity: FNDC5 gene interactions with candidate genes FOXOA3 and APOE.

Noriyuki Fuku, Roberto Díaz-Peña, Yasumichi Arai, Yukiko Abe, Hirofumi Zempo, Hisashi Naito, Haruka Murakami, Motohiko Miyachi, Carlos Spuch, José A Serra-Rexach and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. How Important Are Genes to Achieve Longevity?International journal of molecular sciences · 2022
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Genetic and epigenetic regulation of human aging and longevity.Biochimica et biophysica acta. Molecular basis of disease · 2019
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Noriyuki FukuGraduate School of Health and Sports Science, Juntendo University, Chiba, Japan. noriyuki.fuku@nifty.com.
Roberto Díaz-PeñaHospital Universitari Institut Pere Mata, IISPV, URV. CIBERSAM, Reus, Spain.
Yasumichi AraiCenter for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan.
Yukiko AbeCenter for Supercentenarian Medical Research, Keio University School of Medicine, Tokyo, Japan.
Hirofumi ZempoGraduate School of Health and Sports Science, Juntendo University, Chiba, Japan.
Hisashi NaitoGraduate School of Health and Sports Science, Juntendo University, Chiba, Japan.
Haruka MurakamiDepartment of Physical Activity Research; National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.
Motohiko MiyachiDepartment of Physical Activity Research; National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.
Carlos SpuchNeurology Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Centro de investigación biomédica en red del área de salud mental (CIBERSAM), Vigo, Spain.
José A Serra-RexachCentro de investigación biomédica en Envejecimiento y Fragilidad (CIBERFES), Madrid, Spain.
Enzo Emanuele2E Science, Robbio, (PV), Italy.
Nobuyoshi HiroseGraduate School of Health and Sports Science, Juntendo University, Chiba, Japan.
Alejandro LuciaEuropean University and Research Institute i+12, Madrid, Spain.
Juntendo University · JPKeio University · JPNational Institute of Biomedical Innovation, Health and Nutrition · JPCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable · ESCentro de Investigación Biomédica en Red de Salud Mental · ESUniversidad Autónoma de Chile · CLUniversidad Europea de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundForkhead box O3A (FOXOA3) and apolipoprotein E (APOE) are arguably the strongest gene candidates to influence human exceptional longevity (EL, i.e., being a centenarian), but inconsistency exists among cohorts. Epistasis, defined as the effect of one locus being dependent on the presence of 'modifier genes', may contribute to explain the missing heritability of complex phenotypes such as EL. We assessed the potential association of epistasis among candidate polymorphisms related to physical capacity, as well as antioxidant defense and cardiometabolic traits, and EL in the Japanese population. A total of 1565 individuals were studied, subdivided into 822 middle-aged controls and 743 centenarians.

resultsWe found a FOXOA3 rs2802292 T-allele-dependent association of fibronectin type III domain-containing 5 (FDNC5) rs16835198 with EL: the frequency of carriers of the FOXOA3 rs2802292 T-allele among individuals with the rs16835198 GG genotype was significantly higher in cases than in controls (P < 0.05). On the other hand, among non-carriers of the APOE 'risk' ε4-allele, the frequency of the FDNC5 rs16835198 G-allele was higher in cases than in controls (48.4% vs. 43.6%, P < 0.05). Among carriers of the 'non-risk' APOE ε2-allele, the frequency of the rs16835198 G-allele was higher in cases than in controls (49% vs. 37.3%, P < 0.05).

conclusionsThe association of FDNC5 rs16835198 with EL seems to depend on the presence of the FOXOA3 rs2802292 T-allele and we report a novel association between FNDC5 rs16835198 stratified by the presence of the APOE ε2/ε4-allele and EL. More research on 'gene*gene' and 'gene*environment' effects is needed in the field of EL.

Indexed as

Epistasis, GeneticExerciseAdultApolipoproteins EFemaleFibronectinsForkhead Box Protein O3Gene FrequencyGenotypeHumansLongevityMaleMiddle AgedPolymorphism, Single NucleotideYoung AdultApolipoproteins EFibronectinsFNDC5 protein, humanForkhead Box Protein O3FOXO3 protein, humanAgeingAPOECentenariansExceptional longevityFNDC5FOXO3A

Identifiers

PMID29143599
PMCPMC5688477
OpenAlexW2770673378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.